19
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Coagulation and Fibrinolysis Parameters in Normal and in Hypertensive Pregnancies

, , , , &
Pages 115-123 | Published online: 07 Jul 2009

References

  • Weenink G H, Borm J J, Ten-Cate J W, Treffers PE. Antithrombin III levels in nor-motensive and hypertensive pregnancy. Gynecol Obstet Invest 1983; 16: 230–42
  • De Boer K, Ten-Cate J W, Sturk A, Borrn JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–100
  • Terao T, Maki M, Ikenoue T. The relationship between clinical signs and hypercoagulable state in toxemia in pregnancy. Gynecol Obstet Invest 1991; 31: 74–85
  • Caron C, Goudemand J, Marey A. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy associated hypertension. Thromb Haemost 1991; 66: 410–4
  • Aznar J, Estelles A, Gilabert J. Modificacion de la hemostasia durante la gestacion, parto y puerpeno. Clinica Gineco-logica: Alteraciones de la Hemostasisa en Obstetricia, J Gilabert, M Galbis, J Aznar, J Monleon. Salvat ed., Barcelona 1988; 90–102
  • Gilabert J, Fernandez J A, España F, Aznar J, Estelles A. Physiological coagulation inhibitors (protein S protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thromb Res 1988; 49: 319–29
  • Weiner C P, Brandt J. Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 1980; 56: 601–3
  • Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin complexes and D-dimer. Gynecol Obstet Invest 1987; 24: 170–8
  • Xu C, Zhou L, Shong S. Antithrombin III activity in Chinese women in preeclampsia. Thromb Res 1990; 59: 401–6
  • Reinthaller A, Mursch-Edlmayr G, Tatra G. Thrombin antithrombin complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990; 97: 506–10
  • Andrew M, Mitchell L, Berry L. An anticoagulant dermatan sulfate proteogly-can circulates in the pregnant woman and her fetus. J Clin Invest 1992; 89: 321–6
  • Anderson TR. Consumption of heparin cofactor II (dermatan sulfate factor) and antithrombin during coagulation. Thromb Res 1987; 46: 355–62
  • Bonnar J, McNicol G P, Douglas AS. Coagulation and fibnnolytic system in preéclampsia and eclampsia. Br Med J 1976; 3: 12–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.